Consistent with the previous findings22, Studies also suggest that proteasome inhibitors could be used as immunosuppressive agentsintraperitoneal BTZ injection markedly inhibited the accumulation of proinflammatory cells, including Mac-2-macrophages and CD4+ T cells in the aneurysm wall induced by Ang II infusion (Fig. 5a–c). The gene discussed is CD4; the disease is aneurysm.